Cancer Diagnostics Market Revenue 2024 to 2034
Cancer Diagnostics Market Revenue 2024 to 2034
The cancer diagnostics market will grow from USD 156.25 Bn in 2024 to USD 357.21 Bn by 2034, at an 8.62% CAGR, driven by early screening adoption, biomarker-based tests, and advanced imaging technologies.
Report ID: 10554
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 156.25 Bn
Forecast Year,
USD 357.21 Bn
CAGR, 2025 -
8.62%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cancer Diagnostics Market Size Analysis
Cancer Diagnostics Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | 75.00 | 81.68 | 88.96 | 96.89 | 105.52 | 114.91 | 125.15 | 136.29 | 148.42 | 161.62 | 176.00 |
| Instruments | 56.25 | 60.78 | 65.67 | 70.96 | 76.67 | 82.84 | 89.51 | 96.71 | 104.49 | 112.89 | 121.97 |
| Services | 25.00 | 27.26 | 29.71 | 32.39 | 35.31 | 38.49 | 41.96 | 45.74 | 49.86 | 54.34 | 59.23 |
Cancer Diagnostics Market Size By Test Type 2024 to 2034 (USD )
| Test Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Imaging | 53.13 | 57.97 | 63.25 | 69.01 | 75.29 | 82.15 | 89.63 | 97.79 | 106.69 | 116.40 | 126.99 |
| Lab Tests/IVD | 65.63 | 71.07 | 76.96 | 83.34 | 90.25 | 97.73 | 105.82 | 114.59 | 124.08 | 134.35 | 145.47 |
| Biopsy | 25.00 | 26.91 | 28.97 | 31.18 | 33.56 | 36.12 | 38.86 | 41.81 | 44.98 | 48.38 | 52.04 |
| Others | 12.50 | 13.77 | 15.17 | 16.71 | 18.40 | 20.26 | 22.30 | 24.55 | 27.02 | 29.73 | 32.71 |
Cancer Diagnostics Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast | 28.13 | 30.21 | 32.45 | 34.85 | 37.42 | 40.18 | 43.15 | 46.32 | 49.73 | 53.37 | 57.29 |
| Lung | 28.13 | 30.85 | 33.84 | 37.12 | 40.70 | 44.63 | 48.93 | 53.64 | 58.79 | 64.43 | 70.61 |
| Colorectal | 18.75 | 20.59 | 22.60 | 24.81 | 27.23 | 29.88 | 32.78 | 35.96 | 39.45 | 43.26 | 47.44 |
| Prostate | 15.63 | 17.14 | 18.79 | 20.60 | 22.58 | 24.75 | 27.13 | 29.73 | 32.57 | 35.69 | 39.10 |
| Other Cancers | 65.63 | 70.93 | 76.67 | 82.86 | 89.56 | 96.80 | 104.63 | 113.08 | 122.22 | 132.10 | 142.77 |
Cancer Diagnostics Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 78.13 | 84.91 | 92.28 | 100.29 | 109.00 | 118.46 | 128.75 | 139.93 | 152.08 | 165.28 | 179.63 |
| Diagnostics Labs | 56.25 | 60.89 | 65.91 | 71.34 | 77.22 | 83.58 | 90.46 | 97.91 | 105.96 | 114.67 | 124.10 |
| Others | 21.88 | 23.92 | 26.16 | 28.61 | 31.28 | 34.21 | 37.40 | 40.90 | 44.72 | 48.90 | 53.47 |
Cancer Diagnostics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 56.25 | 61.29 | 66.78 | 72.76 | 79.27 | 86.36 | 94.09 | 102.50 | 111.67 | 121.65 | 132.51 |
| Europe | 43.75 | 47.64 | 51.88 | 56.49 | 61.51 | 66.97 | 72.92 | 79.39 | 86.44 | 94.12 | 102.47 |
| Asia Pacific | 45.31 | 49.18 | 53.39 | 57.95 | 62.90 | 68.28 | 74.12 | 80.45 | 87.33 | 94.80 | 102.90 |
| Latin America | 6.25 | 6.57 | 6.90 | 7.24 | 7.59 | 7.94 | 8.30 | 8.67 | 9.04 | 9.42 | 9.79 |
| Middle East & Africa | 4.69 | 5.03 | 5.41 | 5.80 | 6.23 | 6.69 | 7.18 | 7.71 | 8.27 | 8.88 | 9.53 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
